Medication info

Hilone 5 Injection (Sodium Hyaluronate)

Prescription medicationInjectionsApproval withdrawn
Ingredient · strength
Sodium Hyaluronate›23mg / 1mL
Manufacturer / importer
MEDITIP
Appearance
A colorless, viscous liquid in a single-use container, injectable solution
Packaging
Manufacturer packaging unit - 0.6 milliliters/cylinder
Approval status
Approval withdrawn

MFDS item code 200603998 · Notified 2006.03.23

This product's status changed to Approval withdrawn on 2024.07.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Adjunctive treatment for ophthalmic surgery (cataract surgery, corneal transplantation, etc.)
Who uses it
Adults
Adult dosage
1. Cataract surgery and intraocular lens implantation: Slowly inject the required amount of this medicine into the anterior chamber of the eye using a needle or cannula, before or after lens removal. Inject before intracapsular or extracapsular cataract surgery to optimize its corneal endothelial protection as an adjunct, which requires administration before cataract extraction and intraocular lens implantation. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation: After removing the corneal graft, fill the anterior chamber with this medicine until the level is even with the corneal surface. Place the donor graft on top of this medicine and suture it in place. 3. Glaucoma filtration surgery: Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Ingredients

Importer
MEDITIP

Efficacy & effects

Adjunctive treatment for ophthalmic surgery (cataract surgery, corneal transplantation, etc.)

View approved original text

This medication is used as an adjunct in various ophthalmic surgeries such as intraocular lens implantation during cataract surgery, corneal transplant surgery, and glaucoma surgery. It helps with recovery after surgery and prevents complications. Used as an auxiliary agent in these surgeries, it enhances surgical outcomes and facilitates the treatment process.

Dosage and Administration

Adult dosage

1. Cataract surgery and intraocular lens implantation: Slowly inject the required amount of this medicine into the anterior chamber of the eye using a needle or cannula, before or after lens removal. Inject before intracapsular or extracapsular cataract surgery to optimize its corneal endothelial protection as an adjunct, which requires administration before cataract extraction and intraocular lens implantation. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation: After removing the corneal graft, fill the anterior chamber with this medicine until the level is even with the corneal surface. Place the donor graft on top of this medicine and suture it in place. 3. Glaucoma filtration surgery: Inject this medicine through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.

Precautions

This medication should not be used in patients with a history of allergy to its components or to protein-based drugs. When used in the eye, it may sometimes cause an increase in intraocular pressure. Rarely, issues such as ocular inflammation, corneal edema, or corneal opacity may occur. Additionally, various eye-related side effects, including bleeding in the anterior chamber or neovascularization of the iris, can occur, which should be monitored closely. After using this medication, opacifications may develop on the surface of the intraocular lens. This medication contains phosphates, which may rarely lead to calcification of the cornea in patients with severe corneal damage; therefore, it should be used with caution. Particularly right after surgery, intraocular pressure should be monitored frequently, and if the pressure increases, appropriate treatment should be obtained. After surgery, it is advisable to rinse or aspirate this medication to remove it from the eye whenever possible. During ultrasound emulsification, a space filled with irrigation fluid must be created between the drug and the lens to ensure safety. When cleaning surgical instruments, solutions containing quaternary ammonium compounds like benzalkonium chloride should not be used. This medication should not be used in conjunction with another drug called hyaluronidase. It must be used only for ophthalmic purposes and must not be injected intravascularly under any circumstances. Store the medication in the refrigerator, and allow it to sit at room temperature for about 30 minutes before use. Care should be taken to avoid precipitate formation when mixed with components such as benzalkonium chloride or chlorhexidine. After opening, it should be used only once; any remaining medication should be discarded with the container. Care must be taken to avoid introducing air into the eye when using this medication mixed with air. Administer slowly and be cautious not to exceed the recommended amount. Overdosage may lead to increased intraocular pressure post-surgery. Keep the medication out of reach of children, avoid direct sunlight, and store in a cool, dry place sealed tightly. Transferring the medication to another container poses a risk of misuse and may alter its quality; thus, it must be stored in the original container.

Side effects

  • Intraocular pressure increase
  • inflammatory response
  • corneal edema
  • corneal opacity
  • anterior hemorrhage
  • iris neovascularization
  • posterior iris ulcer
  • conjunctival adhesion failure
  • mydriasis
  • lens opacity
Show 6 more
  • pain
  • pruritus
  • blurred vision
  • corneal dystrophy
  • opacity of the intraocular lens surface
  • corneal calcification

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light and should be stored in a tightly sealed container that does not allow light. Additionally, to maintain its efficacy, it should be stored at refrigerated temperatures between 2 and 8 degrees Celsius, ensuring it does not freeze.

Appearance and packaging

Appearance

A colorless, viscous liquid in a single-use container, injectable solution

Package unit

Manufacturer packaging unit - 0.6 milliliters/cylinder

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.